HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

FDA Peanut Butter Warning

Share
January 20, 2009 | Comment(s): 0
Recommended this article (6)
JNJ | HSY | K

Companies cited here include Kellogg's (K - Analyst Report), Hershey's (HSY - Analyst Report) and Johnson & Johnson (JNJ - Analyst Report).

The FDA is investigating a peanut paste supplier, Peanut Corporation of America, in connection with a fatal outbreak of salmonella contamination that has hospitalized at least 90 persons and is being blamed for six deaths. Salmonella are bacteria that cause diarrhea, cramping, and fever. The FDA is urging consumers to avoid eating cookies, cakes, ice cream and other foods that contain peanut butter.

As a result, Kellogg's (K - Analyst Report) has recalled certain Austin and Keebler brands of crackers and cookies that contain peanut butter obtained from the Peanut Corporation of America.

On the other hand, Hershey (HSY - Analyst Report) is not affected by the outbreak in that the company does not purchase any peanut butter, peanuts, or peanut products from the Peanut Corporation of America. Peanut butter for Reese's Peanut Butter Cups is made in Hershey's own facilities under the company's oversight.

In general, product recalls in the consumer staples sector are not major drivers of a company's stock price. During the time of a product recall, demand weakens as consumers avoid the product for a limited period of time. Also, the companies experience inventory write-offs as the recalled products are destroyed. However, these events do not affect the organic earnings power from the continuing operations of the companies. Stock price weakness as a result of a product recall usually offers attractive entry points.

Even when the product recall requires permanent incremental costs going forward, such as the increased packaging costs Johnson & Johnson (JNJ - Analyst Report) experienced after cyanide-laced Tylenol capsules were discovered in October 1982, the 10% decline in the stock's price was quickly reversed within weeks.

Read the full analyst report on K

Read the full analyst report on HSY

Read the full analyst report on JNJ


Read the full analyst report on JNJ

Read the full analyst report on HSY

Read the full analyst report on K

 

Please login to Zacks.com or register to post a comment.


Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 25, 2012 08:33 am ET
DJIA 12529.75  0.00 0.00%
NASD 2839.38  0.00 0.00%
S&P 500 1320.68  0.00 0.00%
Partner Center